Abiopharma

Oculis birtir uppgjör fyrir þriðja ársfjórðung 2025 og kynnir áfanga í rekstri félagsins

Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance

UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™

Quanterix Releases Financial Results for the Third Quarter of 2025

Xencor to Participate at Upcoming Investor Conferences

Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress

Veradigm Adds Sentara Health Plans to Veradigm Payer Insights Solution

Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

AWH Announces Third Quarter 2025 Financial Results

TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit